Read More
Both natural variation in ACE concentrations and lowering BP with ACE inhibitors associated with lower risk of T2D
New research presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 September) shows that usage of angiotensin-converting enzyme (ACE) inhibitors to lower blood pressure, is associated with a 24% reduced risk of developing type 2 diabetes (T2D) when compared with placebo.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
Read More
Subscribe to:
Post Comments (Atom)
0 Response to "Both natural variation in ACE concentrations and lowering BP with ACE inhibitors associated with lower risk of T2D"
Post a Comment